Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go , its ambient AI medical documentation product.
- SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go , its ambient AI medical documentation product.
- Now supporting over 50 medical specialties, the Augmedix Go mobile app optimizes ambient AI technology to produce comprehensive draft medical notes in real time by processing the natural conversations between clinicians and patients.
- Additionally, 94% of clinicians surveyed reported that Augmedix Go helps them better focus on their patients.
- By utilizing multiple models that cross-check each other, Augmedix is delivering high quality notes that instill trust among clinicians.